These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 20924261

  • 21. Ranibizumab treatment in patients with neovascular age-related macular degeneration and very low vision.
    Sørensen TL, Kemp H.
    Acta Ophthalmol; 2011 Feb; 89(1):e97. PubMed ID: 20384603
    [No Abstract] [Full Text] [Related]

  • 22. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H, Abrams P.
    Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
    [Abstract] [Full Text] [Related]

  • 23. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [Abstract] [Full Text] [Related]

  • 24. Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd.
    Keane PA, Chang KT, Liakopoulos S, Jivrajka RV, Walsh AC, Sadda SR.
    Retina; 2009 May; 29(5):592-600. PubMed ID: 19289984
    [Abstract] [Full Text] [Related]

  • 25. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration.
    Shah AR, Del Priore LV.
    Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101
    [Abstract] [Full Text] [Related]

  • 26. Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial.
    Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE, Kim IK.
    Ophthalmology; 2011 Jan; 118(1):111-8. PubMed ID: 20678799
    [Abstract] [Full Text] [Related]

  • 27. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.
    Ferrara N, Damico L, Shams N, Lowman H, Kim R.
    Retina; 2006 Oct; 26(8):859-70. PubMed ID: 17031284
    [Abstract] [Full Text] [Related]

  • 28. In vivo three-dimensional imaging of neovascular age-related macular degeneration using optical frequency domain imaging at 1050 nm.
    de Bruin DM, Burnes DL, Loewenstein J, Chen Y, Chang S, Chen TC, Esmaili DD, de Boer JF.
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4545-52. PubMed ID: 18390638
    [Abstract] [Full Text] [Related]

  • 29. Ranibizumab according to need: a treatment for age-related macular degeneration.
    Spaide R.
    Am J Ophthalmol; 2007 Apr; 143(4):679-80. PubMed ID: 17386275
    [No Abstract] [Full Text] [Related]

  • 30. Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes.
    Raja MS, Saldana M, Goldsmith C, Burton BJ.
    Br J Ophthalmol; 2010 Nov; 94(11):1543-5. PubMed ID: 20516142
    [No Abstract] [Full Text] [Related]

  • 31. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2.
    Abraham P, Yue H, Wilson L.
    Am J Ophthalmol; 2010 Sep; 150(3):315-324.e1. PubMed ID: 20598667
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of ranibizumab-induced changes in high-resolution optical coherence tomographic retinal morphology and their impact on visual function.
    Kiss CG, Geitzenauer W, Simader C, Gregori G, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2376-83. PubMed ID: 19136707
    [Abstract] [Full Text] [Related]

  • 33. Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic therapy.
    Jyothi S, Chowdhury HR, Chong V, Sivaprasad S.
    Eye (Lond); 2010 Jun; 24(6):1018-23. PubMed ID: 19893588
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of ranibizumab for neovascular age-related macular degeneration using clinician-determined retreatment strategy.
    Kumar A, Sahni JN, Stangos AN, Campa C, Harding SP.
    Br J Ophthalmol; 2011 Apr; 95(4):530-3. PubMed ID: 20937739
    [Abstract] [Full Text] [Related]

  • 35. Cystoid macular degeneration in exudative age-related macular degeneration.
    Querques G, Coscas F, Forte R, Massamba N, Sterkers M, Souied EH.
    Am J Ophthalmol; 2011 Jul; 152(1):100-107.e2. PubMed ID: 21570056
    [Abstract] [Full Text] [Related]

  • 36. Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
    Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, ANCHOR Study Group.
    N Engl J Med; 2006 Oct 05; 355(14):1432-44. PubMed ID: 17021319
    [Abstract] [Full Text] [Related]

  • 37. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
    Antoszyk AN, Tuomi L, Chung CY, Singh A, FOCUS Study Group.
    Am J Ophthalmol; 2008 May 05; 145(5):862-74. PubMed ID: 18321465
    [Abstract] [Full Text] [Related]

  • 38. Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.
    Hernandez-Pastor LJ, Ortega A, Garcia-Layana A, Giraldez J.
    Clin Ther; 2008 Dec 05; 30(12):2436-51. PubMed ID: 19167602
    [Abstract] [Full Text] [Related]

  • 39. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.
    Cho M, Barbazetto IA, Freund KB.
    Am J Ophthalmol; 2009 Jul 05; 148(1):70-8.e1. PubMed ID: 19403115
    [Abstract] [Full Text] [Related]

  • 40. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
    Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY, FOCUS Study Group.
    Arch Ophthalmol; 2006 Nov 05; 124(11):1532-42. PubMed ID: 17101999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.